Medical care
-
Memoray completes tens of millions of yuan in Series B financing
Memoray has recently completed a Series B financing of tens of millions of RMB.
This round of financing was jointly invested by Zeyu Capital, Suzhou Proxima Ventures, and Tibet Ruishang Venture Capital. This is a new round of financing after the company received tens of millions of yuan in Series A financing in May this year. -
JD Health and AstraZeneca start strategic cooperation
On November 17, JD Health and AstraZeneca, the world’s leading multinational pharmaceutical company, reached a strategic cooperation.
-
Orthopedic AI company Changmugu closes Series A+ of RMB tens of mlns
Beijing Changmugu Medical Technology, or Changmugu, an orthopedic artificial intelligence high-tech company, recently announced the completion of its Series A+ round of financing worth tens of millions of yuan, which was exclusively invested by Lenovo Ventures.
-
Lu Daopei Medical closes Series B+ exceeding RMB 100 mln
Lu Daopei Medical, a blood disease specialist medical group, has completed its Series B round of financing raising more than 100 million yuan.
-
JD.com reaches strategic cooperation with Tongrentang Health
On September 2nd, phat.jd.com, the health section of JD.com, launched a new service platform of Chinese medicine on which users can inquire about Chinese medicine online and buy the medicine according to the prescription.
-
Tsimaging closes Pre-A round led by BOHE Angel Fund
Recently, Beijing Tsingying Huakang Technology Co., Ltd. or Tsimaging Technology completed its Pre-A round of equity financing worth tens of millions of yuan, led by BOHE Angel Fund and jointly invested by TusStar Ventures.
-
Forerunner Medical closes Series B with hundreds of million in RMB
Forerunner Medical, a medical device technology company, recently announced that it had raised hundreds of millions of yuan in its Series B round of financing; which was led by CICC Capital, and followed by Cenova Capital, Apricot Capital, Dalton Investment and China Renaissance Capital.
-
China Isotope & Radiation Corporation and Bayer agree to introduce Xofigo into China
On September 1, China Isotope & Radiation Corporation (CIRC) signed an exclusive distribution agreement with Bayer.
-
Phase III clinical trial of China’s covid-19 inactivated vaccine launched in Argentina
The world’s first inactivated COVID-19 vaccine developed and produced by Sinopharm Group’s China National Biotec Group (CNBG) was approved by the National Food, Drugs and Medical Technology Administration (ANMAT) under the Ministry of Health of Argentina on August 13 for trial test.
-
China started emergency use of Covid-19 vaccine on July 22
China has officially launched the emergency use of the Covid-19 vaccine on July 22, Zheng Zhongwei, an official of the National Health Commission, said on CCTV’s Dialogue program.